Mixed infection due to leptospira and dengue.
Kaur
Harjeet
H
John
Mary
M
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000293:Adolescent; D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents / Q000627:therapeutic use; D000897:Anti-Ulcer Agents / Q000627:therapeutic use; D001562:Benzimidazoles / Q000627:therapeutic use; D002939:Ciprofloxacin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007922:Leptospirosis / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D009853:Omeprazole / Q000031:analogs & derivatives; D000077402:Pantoprazole; D019595:Severe Dengue / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D013454:Sulfoxides / Q000627:therapeutic use; D013752:Tetracycline / Q000627:therapeutic use
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D000897:Anti-Ulcer Agents; D001562:Benzimidazoles; D013454:Sulfoxides; D002939:Ciprofloxacin; D000077402:Pantoprazole; D013752:Tetracycline; D009853:Omeprazole